Zymergen, Inc. (ZY) plans to raise $401 million in an IPO on Thursday, April 22nd, IPO Scoop reports. The Emeryville, Calif.-based company would raise $421.6 million at the top of that range, and be valued at about $2.96 billion. Zymergen seems to still be focused on research and development, an area where the new funding comes in handy. "I love the symbolism that we're going public on Earth Day," says Zymergen's Josh Hoffman. The company said in a regulatory filing that the IPO is offering 13.6 million shares for $ 28 to $ 31, respectively. ... Bioworks is the true leader with a broader pipeline and more revenue and partnerships. The past few years have been boom times for synthetic biology.Today, in a big test for public markets’ appetite for the emerging field, Zymergen raised $500 million in an initial public offering set to value the company at more than $3 billion. The company said in a regulatory filing that in the IPO it was offering 13.6 million shares at $28 to $31 each. Between December 2018 and its IPO, Zymergen raised $700 million from investors as a private company. (April 22): Zymergen Inc., which uses biological processes to manufacture chemicals, raised US$500 million in an upsized initial public offering priced at the top of a marketed range.The company sold 16.13 million shares Wednesday for $31 each, according to a statement. Zymergen has a market cap or net worth of $3.44 billion. We call it the materials superhighway to suggest an awesome speed of innovation, a connection back to the genetics revolution and the information superhighway, and a focus on the new materials, chemicals, substances, and energies of the advanced bioeconomy. The average deal size rose to $29.8 million; and the average valuation increased to $134.2 million. shares in the price range of $28.00-$31.00. Zymergen, Inc. has a market cap […] ET (Note: Zymergen, Inc. upsized its IPO at pricing on April 21, 2021, to 16.3 million shares, up from 13.6 million in the prospectus, at $31 – the top of its $28-to-$31 price range – to raise $505.3 million.) It had marketed 13.6 million shares for US$28 to US$31.Zymergen has market value of about US$3 billion based on … Biotechnology Zymelgen (((ZY)- Get the report On Wednesday, we launched a roadshow for an initial public offering (a series of presentations to investors). IPO: Zymergen’s Valuation Soars to $8 Billion On Market Debut. On Wednesday, Sana filed paperwork for an IPO without a single drug in clinical trial. In California, Zymergen raised $500 million last week in its IPO and the stock closed Monday night at $43.00, up 39 percent over itsWednesday trading debut. That superhighway may have just found its Porsche 911 — fast as lightning, stunning design and a public reception because of … The shares were up 17% to $36.20 at 2:17 p.m. in New York trading, giving the company a market value of about $3. Welcome to /r/IPO a subreddit dedicated to news articles and S-1 filings for the newest IPOs. Zymergen's upsized IPO prices at top of expected range, valuing 'biofacturing' company at $3 billion Published: April 22, 2021 at 8:54 a.m. Including employee stock options, that valuation … Zymergen’s upsized IPO prices at top of expected range, valuing ‘biofacturing’ company at $3 billion Posted by: Market Watch in Market News 26 days ago Zymergen made a splash on Earth Day, as the first “biofacturer” to go public. Today's IPO for biofacturing company Zymergen Inc. (NASDAQ: ZY) opened for trading at $40.30 after pricing 16,130,000 shares of its common stock … The enterprise value is $3.29 billion. Zymergen, an Emeryville, California–based synthetic biotechnology firm, recently raised $500 million in an initial public offering (IPO) of stock on the NASDAQ exchange that values the 8-year-old company at over $3 billion. ". Zymergen Inc. is set to go public Thursday, after the biofacturing company's upsized initial public offering priced at $31 a share, at the top of the expected range. Zymergen, a biotech that engineers microbes to produce bio-based products, upsized its IPO, offering more than 16.1 million shares at $31 apiece. Zymergen is a biofacturing company using biology to reimagine the world. Zymergen made a splash on Earth Day, as the first "biofacturer" to go public. Zymergen, a synthetic biology company, has set the price range for its IPO.The Emeryville, Calif.-based company intends to sell 13.6 million shares at between $28 and $31 apiece. Zymergen’s platform integrates automation, machine learning, … Before now, Zymergen is known to have raised north of $500 million in funding. Zymergen cofounder and CEO Josh Hoffman. The IPO values the company in excess of $4 billion. In short, every sign from the market is bullish. During the IPO process, the company plans to sell 13.6 million. Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH: Employees: 762: Founded: 2013: Contact Information: Address In the last twelve months, Zymergen, Inc. generated $13.3 million in revenue and had a net loss of $262.2 million. The company plans to issue 13,600,000 shares at $28.00-$31.00 per share. Zymergen is a biotechnology company that specializes in the fields of machine learning, big data, and artificial intelligence. Freshfields served as as issuer’s counsel to Zymergen Inc. on its IPO as a public benefit corporation on the Nasdaq Global Select Market. A capital magnet . May 19, 2021 May 19, 2021 by Staff. Share prices have risen steadily since the initial offering, putting the company’s valuation at more than $4 billion as of this writing, in what could be a promising sign for scaling up green chemistry solutions.risen steadily since the initial offering, putting the The company partner with nature to create materials and products across industries from agriculture to electronics, consumer care to pharmaceuticals, and more. On April 21, the company took in another $500 million in a successful initial public offering ().Zymergen’s most advanced products are impressive, but they haven’t produced significant revenue yet. It develops molecules for agriculture, chemicals, materials, pharmaceuticals, electronics, personal care, and more applications. The … The synthetic biology company raised $500 million in an IPO set to value … Filed 2021-03-23 Terms Added 2021-04-13: For IPO Boutique's "scale of 1 to 5" BUY rating on Zymergen Inc., and our comprehensive analysis, click "Buy Market Research. Zymergen researches, develops, and manufactures microbes for companies. Zymergen has submitted an application to the SEC and is going public at the end of March. Biotech Zymergen (ZY) - Get Report on Wednesday launched a roadshow -- a series of presentations to investors -- for its initial public offering. I will probably still invest in Zymergen and hope for a fair valuation at this stage since they only have one active product at the moment: Hyaline. (Bloomberg) -- Zymergen Inc., which uses biological processes to manufacture chemicals, rose as much as 33% after expanding its initial public offering to raise $500 million. The shares were up 17% to $36.20 at 2:17 p.m. in New York trading, giving the company a market value of about $3.5 billion. Zymergen Inc. , a biofacturing company, launched the roadshow for its initial public offering on Wednesday with plans to offer 13.6 million shares priced at $28 to $31 each. The company sold an unexpectedly robust $16.1 million shares at $31, the top end of its expected range. Underwriters, led by JP Morgan and Goldman Sachs, have the option to purchase an additional … Zymergen, traded on the ticker symbol ZY on the Nasdaq, … CLINTON PERRY PHOTOGRAPHY 2019. 1. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value … April 15, 2021 Zymergen, an Emeryville, Calif.-based synthetic biology company, set IPO terms to 13.6 million shares at $28–$31.It would have a fully diluted market value of $3 billion, were it to price in the middle, and plans to list on the Nasdaq (ZY). Share prices have risen steadily since the initial offering, putting the company’s valuation at more than $4 billion as of this writing, in what could be a promising sign for scaling up green chemistry solutions.. At the top of that range, Zymergen would raise $421.6 million and fetch a valuation of $2.96 billion. In the case of the successful IPO, Zymergen will … Zymergen launched its first commercially available product in April of this year. Facebook Twitter. Total Valuation.
Led Zeppelin Vs Pink Floyd, Reser's Fine Foods, Bluebird Activate, Simple Simon's Beast Pizza, Groome Transportation Cheyenne, Restaurants In Clinton, Ok, New Epping Affordable Housing, Best Cheapest Icons Fifa 21, Is Trading Post Trail Open, Steel Lure - Pixelmon,
Add Comment